Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RANOLAZINE vs REBIF: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RANOLAZINE vs REBIF: Safety Overview

Metric RANOLAZINE REBIF
Total FAERS Reports 9,522 1,748
Deaths Reported 1,048 90
Death Rate 11.0% 5.1%
Hospitalizations 3,367 553
Average Patient Age 70.4 yrs 46.1 yrs
% Female Patients 42.0% N/A
FDA Approval Date Apr 15, 2025 N/A
Manufacturer AvKARE N/A
Route ORAL N/A
Marketing Status Discontinued N/A